PPH icon

VanEck Pharmaceutical ETF
PPH

Overview Fund Activity

50 hedge funds and large institutions have $71M invested in VanEck Pharmaceutical ETF in 2017 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 16 increasing their positions, 15 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
50
Holders Change
–
Holders Change %
0%
% of All Funds
1.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
16
Reduced
15
Closed
5
Calls
–
Puts
$313K
Net Calls
-$313K
Net Calls Change
-$313K

Top Buyers

1
RJFSA
Raymond James Financial Services Advisors
Florida
+$2.54M
2
VKH
Virtu KCG Holdings
New York
+$969K
3
TRCT
Tower Research Capital (TRC)
New York
+$962K
4
VF
Virtu Financial
New York
+$804K
5
Citadel Advisors
Citadel Advisors
Florida
+$363K

Top Sellers

1
Goldman Sachs
Goldman Sachs
New York
-$23.6M
2
Citigroup
Citigroup
New York
-$20.7M
3
Bank of America
Bank of America
North Carolina
-$800K
4
CCT
Country Club Trust
Missouri
-$688K
5
Morgan Stanley
Morgan Stanley
New York
-$670K
Name Holding Trade Value Shares
Change 		Shares
Change %
Susquehanna International Group
51
Susquehanna International Group
Pennsylvania
– -$335K -6,073 Closed
Jane Street
52
Jane Street
New York
– -$241K -4,362 Closed
WP
53
WealthPLAN Partners
Nebraska
– -$21.8K -400 Closed
Simplex Trading
54
Simplex Trading
Illinois
– -$14K -268 Closed
1 2
3